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Abstract
Background: Nestin is a known marker of neuronal progenitor cells in the adult brain. Following neuro- and
gliogenesis, nestin is replaced by cell type-specific intermediate filaments, e.g., neurofilaments for panneuronal
expression and glial fibrillary acidic protein as a specific marker of mature astrocytes. While previous work have
been mostly focused on the neuronal fate of nestin-positive progenitors, in the present study, we sought to
investigate in real time how nestin signals and cellular expression patterns are controlled in the context of
neuroinflammatory challenge and ischemic brain injury.
Methods: To visualize effects of neuroinflammation on neurogenesis/gliogenesis, we created a transgenic model
bearing the dual reporter system luciferase and GFP under transcriptional control of the murine nestin promoter.
In this model, transcriptional activation of nestin was visualized from the brains of living animals using
biophotonic/bioluminescence molecular imaging and a high resolution charged coupled device camera. Nestin
induction profiles in vivo and in tissue sections were analyzed in two different experimental paradigms: middle
cerebral artery occlusion and lipopolysaccharide-induced innate immune stimuli.
Results: We report here a context- and injury-dependent induction and cellular expression profile of nestin.
While in the baseline conditions the nestin signal and/or GFP expression was restricted to neuronal progenitors,
the cellular expression patterns of nestin following innate immune challenge and after stroke markedly differed
shifting the cellular expression patterns towards activated microglia/macrophages and astrocytes.
Conclusions: Our results suggest that nestin may serve as a context-dependent biomarker of inflammatory
response in glial cells including activated microglia/macrophages.
Keywords: In vivo imaging, Inflammation, Stroke, Immune biomarkers, Nestin, Microglia
Background
Nestin is a class IV intermediate filament [1] highly
expressed in the multipotent stem cells of the develop-
ing central nervous system (CNS). In the adult brain,
and in physiological conditions, nestin is predominately
expressed in stem cells in the subventricular zone (SVZ)
or at low levels in the choroid plexus, and it is consid-
ered as a marker of progenitor cells. To date, it has been
widely established that nestin-positive progenitor cells
may differentiate into a variety of CNS cells including
neurons, astrocyte, and oligodendrocytes [2, 3]. Follow-
ing neuro- and gliogenesis, nestin is replaced by the cell
type-specific intermediate filaments, e.g., neurofilaments
for panneuronal expression and glial fibrillary acidic pro-
tein (GFAP), a marker of mature astrocytes. Surprisingly,
recent evidence revealed that in the adult mouse brain,
following resident microglia depletion/repopulation
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experiments, the majority of the newly differentiated
Iba-1-positive cells were also expressing nestin [4]. This
suggests that a subpopulation of nestin-positive cells may
potentially differentiate into fully ramified resident micro-
glia [4]. Microglia are the principal immune cells in the
brain and previous evidence strongly suggests that neuro-
inflammation and innate immune signals may modulate
neurogenesis, CNS progenitor proliferation, migration,
differentiation, survival, and incorporation of newly born
neurons into the CNS circuitry [2, 5]. Importantly and in
accordance with Rolls and colleagues [6], by using in vivo
bioluminescence/biophotonic imaging of innate immune
response in the Toll-like receptor 2 (TLR2) reporter
mouse model generated in our laboratory, we observed
that immune signals in certain conditions could be de-
tected not only in microglia but also in doublecortin
(DCX)-positive neural progenitors [7].
While previous work have been mostly focused on the
neuronal fate of nestin-positive progenitors, in the
present study, we sought to investigate in real time how
nestin signals and its cellular expression patterns are
controlled in the context of neuroinflammatory, innate
immune challenge and ischemic brain injury. To
visualize the nestin signal from the brains of living mice,
we created a transgenic model co-expressing reporter
genes luciferase (luc) and green fluorescent protein
(GFP) under transcriptional control of the murine nestin
gene promoter. The advantage of the dual reporter sys-
tem emerged from the fact that fluorescence signals can
be used to achieve microscopic resolution and detection
of the GFP signals from the specific cell subtypes, while
bioluminescence, owing to favorable emission spectra of
luciferase (above 620 nm), is optimized for live whole
animal imaging [7, 8]. In the present study, we describe
a novel transgenic model system for in vivo biolumines-
cence and fluorescence imaging of nestin and we report
here a context- and injury-dependent induction and a
marked shift in cellular expression patterns of nestin.
While in physiological conditions the nestin signal (and/
or GFP expression) is indeed restricted to neural
progenitors (NPGs) in their typical niche regions, the in-
duction and/or cellular expression patterns of nestin
markedly differ in neuroinflammatory conditions. Fol-
lowing innate immune challenge by lipopolysaccharide
(LPS) injection and in response to ischemic injury, we
observed a marked shift in the nestin cellular expression
patterns towards activated microglia/macrophages and
astrocytes. Based on our findings, we propose that nestin
may have a role as a context-dependent biomarker.
Methods
Generation of transgenic mice
The rat promoter of the nestin gene was amplified from
the recombinant plasmid pNERV [9] using a high-
fidelity polymerase. The 5.1-kb fragment was subcloned
into a TOPO vector, sequenced, and inserted into the re-
combinant plasmid pIRES-Luc2-AcGFP. To preferen-
tially direct the transgene expression into CNS, a 654-bp
fragment containing the second intron of the rat nestin
gene was also amplified from the pNERV recombinant
plasmid and inserted between the Cla1 restriction sites
at the end of the final construct [1]. The construct
pIRES-rNestin-promoter-Luc2-AcGFP-int2 was removed
from its host plasmid, purified, and used for microinjec-
tion into the pronuclei of fertilized single cell C57BL/6
albino mouse embryos. The integrity of the final con-
struct was verified by sequencing. Transgenic mice
were generated in the Transgenic and Knockout Facility of
the Research Center of the Centre Hospitalier de l’Univer-
sité Laval (CHUL). Transgenic animals were genotyped by
polymerase chain reaction (PCR) detection of the lu-





Unilateral transient focal cerebral ischemia was induced
as previously described [7, 10, 11] by intraluminal fila-
ment occlusion of the left middle cerebral artery (MCA)
for 90 min followed by a 2-week reperfusion period. The
surgery was carried out on adult, 2–3-month-old (20-
30 g) transgenic nestin-luc-GFP male mice. The animals
were anesthetized with 2% isoflurane in 100% oxygen at
a flow rate of 2 L/min. To avoid cooling, the body
temperature was regularly checked and maintained at
37 °C with a heating pad. The correct placement of the
filament was confirmed by Laser Doppler measurements
(PF5001, Perimed, Sweden) [7, 10, 11]. As previously de-
scribed, to additionally confirm successful MCA occlu-
sion (MCAO), at 6 and 24 h after surgery, the animals
were examined for early neurological deficits [11, 12].
The body temperature was maintained at 37 °C with a
heating pad for 1 week after ischemia. To assess induc-
tion of the nestin bioluminescence/biophotonic signals,
the animals were imaged over the 2-week period follow-
ing MCAO.
In vivo bioluminescence imaging
As previously described [7, 13], the images were gath-
ered using the IVIS 200 Imaging System (PerkinElmer,
Hopkinton, Massachusetts). The luciferase substrate D-
luciferin (150 mg/kg in 0.9% saline) was injected intra-
peritoneally (i.p.) 20 min prior to the imaging session.
The mice were anesthetized with 2% isoflurane in 100%
oxygen at a flow rate of 2 L/min, placed in the heated
light tight imaging chamber, and maintained anesthe-
tized by constant delivery of the 2% isoflurane–oxygen
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mixture at 1 L/min through an IVIS anesthesia manifold.
To obtain baseline expression measurements, all animals
were imaged before and then 24 h, 72 h, and 5, 7, 10,
and 14 days following the injury. The light output was
quantified by determining the total number of photons
emitted per second (p/s) using the Living Image 4.0 ac-
quisition and imaging software (PerkinElmer, Hopkinton,
Massachusetts). Region of interest measurements on the
images were used to convert surface radiance (p/s/cm2/
sr) to source flux or total flux of photons expressed in
photons per seconds. The data were represented as
pseudo color images indicating light intensity (red and
yellow, 5 most intense), which were superimposed over
gray scale reference photographs. For the acquisition of
three-dimensional (3D) images, we acquired gray scale
photographs and structured light images followed by a
series of bioluminescent images using different wave-
lengths (560–660 nm). 3D images were created using
diffuse light imaging tomographic (DLIT) algorithms to
reconstruct for the position, geometry, and strength of
the internal light sources. The modifiable parameters
were analyzed across the wavelengths, source spectrum,
and tissue properties (Living Image 4.0 3D analysis soft-
ware). As previously described, during all imaging ses-
sions, the same parameters have been used across the
groups and time points [13].
Acute and chronic inflammation model (LPS-induced
inflammation)
LPS, a gram-negative bacterial cell surface proteoglycan,
known also as bacterial endotoxin, has been widely used
to activate the innate immune response in both the per-
iphery and the brain. To induce acute and chronic im-
mune challenge, a first group of mice received a single
intraperitoneal (i.p.) injection of LPS (5 mg/kg body
weight) (Sigma Aldrich, USA) while a second group re-
ceived repetitive LPS injections (5 mg/kg body weight,
every 3 days) for 2 weeks. The nestin signal was re-
corded by live imaging over the 2-week period (n = 6/
group) [7]. All experimental procedures on animals were
approved by the Laval University Animal Care commit-
tee and are in accordance with The Guide to the Care
and Use of Experimental Animals of the Canadian
Council on Animal Care.
Tissue collection and immunofluorescence
Animals were anesthetized by a ketamine/xylazine intra-
peritoneal injection (100–10 mg/kg) and then transcar-
dially perfused with 30 mL of 0.9% saline, followed by
4% paraformaldehyde (PFA) at pH 7.4 dissolved in
phosphate-buffered saline (PBS). Tissue samples were
then post-fixed overnight in 4% PFA and equilibrated in
PBS/30% sucrose for 48 h. Tissues were cut with a
microtome (35 μm thick) and stored at −20 °C in
antifreeze solution (5.75 mM sodium phosphate mono-
basic, 19.25 mM sodium phosphate dibasic, 30% ethylene
glycol, 20% glycerol). Every sixth brain section was used
for the experiments. For each animal, six sections were
stained. Tissue sections from antifreeze solution were
washed in PBS1X, mounted on microscopic glass slides,
and then dried for 2 h under vacuum. Sections were
blocked in 1% bovine serum albumin/PBS 1× and incu-
bated overnight at room temperature using primary anti-
bodies, mouse monoclonal nestin 1:250 (Millipore,
Chemicon), 1:750 rabbit polyclonal anti-Iba-1 (Wako),
1:250 goat polyclonal anti-GFP for Fig. 3e (Santa Cruz
Biotechnology), or 1:250 rabbit polyclonal anti-GFP
for Fig. 1e, i, m; Fig. 3b, h, k; and Additional file 1:
Figure S1D, F, and H (Millipore Chemicon), 1:500
rabbit polyclonal anti-glial fibrillary acidic protein
(GFAP; Dako Cytomation) and 1:500 Doublecortin
(Santa Cruz Biotechnology). After PBS 1× washes,
sections were incubated in corresponding fluorescent
secondary antibody (Alexa Fluor 488, 555, 595, 647)
(Thermo Fisher), rewashed, and covered with Fluoro-
mount G medium (Electron Microscopy Sciences).
Images were acquired with a DVC-2000C digital cam-
era (Thorlabs Scientific Imaging, Austin, TX) and an-
alyzed with Stereo Investigator software (MBF
Bioscience, Williston, VT). The same luminosity and
exposure time were used to capture images of all the
experimental groups to standardize the analysis of the
entire experiment. The cell counts were performed
using Neurolucida software (magnification 20×) fol-
lowing the protocol described by Ulrich-Lai et al. [14]
that was adapted for our experiments (SVZ and DG).
Primary cell cultures
Primary cell cultures were obtained from the brains of
PN6-PN8 wild-type pups. Brains were collected and
placed in ice-cold PBS. Following mechanical dissociation,
five or six brains were incubated in a 0.25% trypsin-EDTA
solution (Sigma) containing 250K U/mL DNase I (Sigma).
After centrifugation, the cell pellets were placed in T-
75 cm2 flasks for 7 days at 37 °C, 5% CO2, in DMEM
high-glucose media with 10% fetal bovine serum and anti-
biotic solution (Sigma). At confluence, the cells were
plated onto cover slips in 24 well plates at a concentration
of 40,000 cells/well in media. Cells were incubated with
G-CSF 24 h later to allow adhesion. At day 4 in vitro, cells
were treated with LPS (1 μg/mL) for 24 h and then fixed
with PFA for immunofluorescence experiments [15].
Statistical analysis
Unpaired t test was used to compare the total photon
emission in the two different ROIs in the same mouse at
a same time point when the variances were equivalent
between the two groups. All results are presented as
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mean values ± standard error of the mean (SEM). One-
way ANOVA followed by Tukey’s multiple comparison
tests was used for all cell counts (nestin+, GFAP+, and
Iba-1+ cells) after immunofluorescence experiments in
basal conditions, before/after MCAO, and after LPS in-
jection. Statistical analyses were performed using the
GraphPad Prism 6 software (GraphPad, La Jolla, CA).
Results
Generation of transgenic model for live imaging of the
nestin biophotonic/bioluminescence signals
To visualize the spatial and temporal dynamics of NPG
cellular responses/nestin signal in real time and from the
brains of live animals, we generated transgenic mice
bearing a dual bicistronic reporter system [firefly
luciferase (luc) and GFP] under the transcriptional con-
trol of the nestin gene promoter. The 5.1-kb fragment of
the nestin gene promoter was amplified from the recom-
binant plasmid pNERV and cloned into a TOPO vector
then sequenced and inserted into the recombinant plas-
mid pIRES-Luc2-AcGFP (Fig. 1a). The feasibility of this
approach was clearly demonstrated in our previous stud-
ies [7, 8]. Namely, the advantage of the dual reporter
system emerged from the fact that fluorescence signals
can be used to achieve microscopic resolution while bio-
luminescence, due to favorable emission spectra of lucif-
erase, is optimized for in vivo imaging. Furthermore,
previous studies demonstrated that the expression of
nestin in the neuroepithelial cells is dependent on the
presence of the transcriptional enhancer present in the
Fig. 1 Generation and characterization of nestin-luc/GFP mice. a The rat promoter of the nestin gene was amplified from the recombinant plasmid.
The 5.1-kb fragment was subcloned into a TOPO vector, sequenced, and inserted into the recombinant plasmid pIRES-Luc2-AcGFP. A 654-bp second
intron of the rat nestin gene was also amplified from the pNERV recombinant plasmid and inserted between the Cla1 restriction sites at the end of the
final construct. The construct pIRES-rNestin-promoter-Luc2-AcGFP-int2 was removed from its host plasmid and microinjected into the pronuclei of
fertilized single-cell mouse embryos. b Genotyping PCR analysis for luciferase (Luc2) in the ear tissue of nestin-luc-GFP transgenic mice. c In vivo
imaging of the photon emission in the brain of the nestin-luc-GFP transgenic mice. Immunofluorescent labeling shows the co-localization between
GFP (green) and nestin (red) in nestin-Luc-GFP mice in different neurogenic regions of the brain such as the subventricular zone (d–g), dentate gyrus
(h–k), and olfactory bulb (l–o) (n = 3 mice). The white arrowheads show the double positive cells. Scale bar: 100 μm
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second intron of the gene; therefore, to preferentially
direct the transgene expression into CNS stem cells, a
654-bp fragment containing the second intron of the rat
nestin gene was also amplified from and inserted be-
tween the Cla1 restriction sites at the end of the final
construct [1]. Nine transgenic founders were obtained
using this construct, and following validation analysis,
we focused on the transgenic reporter line with the
strongest signal induction and appropriate nestin-driven
transgene expression. The mice developed normally and,
as expected, did not develop any overt phenotype. As
presented in Fig. 1b, the transgenic mice were genotyped
using PCR with primers aiming at the segment of the
luc transgene (Fig. 1b). To determine the functionality of
the transgene, the animals were screened for in vivo bio-
luminescence signal in control, baseline conditions, fol-
lowing focal brain ischemia and in the context of acute
and chronic neuroinflammatory conditions. We first
assessed the distribution of the nestin signal in the base-
line, control conditions in adult mice. As shown in
Fig. 1c, in physiological conditions, the nestin biolumin-
escence signal was restricted to the olfactory bulb region
and areas reflecting subventricular zones and hippocam-
pus. To further validate our transgenic model, we next
investigated the expression patterns of the nestin-driven
transgenes luciferase and GFP. The analysis of the nestin
signal by in vivo bioluminescence was followed by
double-immunofluorescence analysis confirming the
nestin/GFP co-localization. Moreover, the appropriate
negative control experiments have been performed to
additionally validate our transgenic model and in vivo
imaging approaches (Additional file 1: Figure S1A–C)
as well as the used immunofluorescence protocols
(Additional file 1: Figure S1D–G). As shown in Additional
file 1: Figure S1A–C, the in vivo imaging negative controls
in wild-type (WT) mice were performed in baseline condi-
tions and 24 h after MCAO and LPS injection. Import-
antly, in any of the tested conditions, we did not observe a
non-specific bioluminescence signal. In addition, we also
analyzed brain sections of WT mice for non-specific im-
munofluorescence signals in control conditions as well as
following MCAO and LPS challenge. Importantly, as
shown in Additional file 1: Figure S1D–G, in the tested
conditions, we did not observe a non-specific immuno-
fluorescence staining, thus further confirming the validity
of our transgenic model system.
In the adult brain, neurogenesis persists in two brain
regions referred to as neurogenic niches, the subgranular
zone of the dentate gyrus (DG) in the hippocampus and
the subependyma of the lateral ventricles called the sub-
ventricular zone (SVZ). While SVZ progenitors give rise
to rostral migratory stream and incorporate into the ol-
factory bulb as new olfactory neurons [16], the subgra-
nular zone progenitors migrate to the granule cell layer
of the dentate gyrus and differentiate primarily into gran-
ule cells and/or interneurons [16, 17]. Importantly, the
glial and neuronal progenitors are marked by expression
of the intermediate filament nestin. Previous studies have
demonstrated that in normal condition, there is a low level
of NPG proliferation and nestin expression [16, 17]. In
keeping with previous findings, analysis of the adult brains
in normal conditions revealed a low basal level of the en-
dogenous nestin protein presented in the ventricular zone
(Fig. 1e–g), dentate gyrus (Fig. 1i–k), and olfactory bulb
(Fig. 1m–o) and low levels of the nestin-driven GFP trans-
gene immunoreactivity. As further revealed by double-
immunofluorescence analysis, the majority of nestin-
positive cells co-localize with the GFP, thus suggesting an
adequate transgene expression pattern (Fig. 1e–o). Hence,
in the adult mouse brain and in physiological conditions,
the nestin signal expression is indeed restricted to a
neurogenic niche region comprising the SVZ and DG as
well as the olfactory bulb (OB).
Cerebral ischemia is associated with strong induction of
the nestin biophotonic/bioluminescence signal
To date, it has been widely established that ischemic in-
jury in the brain triggers adult neurogenesis in the SVZ
of the lateral ventricles and the SGZ of the dentate gyrus
[18–21]. Furthermore, cerebral ischemia is associated
with a marked acute and chronic inflammatory response,
events that may significantly affect nestin signal and/or
affect its cellular expression patterns. To visualize the
spatial and temporal dynamics of the nestin signal after
stroke, the transgenic nestin-luc/GFP mice were sub-
jected to 90-min transient MCAO followed by different
reperfusion periods. The imaging protocol was initiated
shortly before stroke (baseline level measurements), and
the same animals were longitudinally imaged starting at
6 h, 24 h, and 3, 5, 7, 10, and up to 14 days after the ini-
tial ischemic injury (Fig. 2a–f ). As expected, analysis of
the baseline nestin signal showed low bioluminescence
baseline levels. The ischemic injury induced a marked
and progressive increase of the nestin signal, reaching its
peak at 24–72 h and 1 week after ischemic lesion. After
day 7, the intensity of the nestin signal slowly decreased
reaching the baseline value at 10 days and stayed at that
level till 2 weeks following stroke (Fig. 2g). As previously
described, to determine whether photons detected by
charge-coupled device camera after cerebral ischemia
were emitted from the appropriate brain regions, we
performed spectral imaging and a 3D reconstruction of
the recorded signals using DLIT algorithms (see the
“Methods” section) 7 days after stroke [13]. As revealed
in Fig. 2h, the 3D signal reconstruction of the bio-
luminescent sources revealed that the nestin signal
was indeed arising from the areas surrounding the
brain structures normally affected by MCAO and
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Fig. 2 Longitudinal imaging of nestin induction/expression following transient MCAO in nestin-luc-GFP mice reveals a long-term induction of
neurogenesis. a–f In vivo imaging of nestin signal induction after MCAO shows the activation of nestin promoter up to 2 weeks post-ischemia.
The color calibrations at right are photon counts. Representative images showed a collection of imaging samples at six different wavelengths (560–660 nm)
across the emission spectrum of the bioluminescent source (firefly luciferase) with the substantial fraction of light over 600 nm. g Plot of the data obtained
by measuring the luciferase activity at the site of ischemic lesion (in photon per second, p/s). The solid black line shows the nestin induction after MCAO. A
strong induction of the promoter at 24 h after MCAO (MCAO vs baseline **p = 0.0154, n = 5) with a peak of expression at 72 h, (MCAO
vs baseline *p = 0.0347, n = 5) as well as smaller peak of expression at 7 days was noted. h 3D reconstruction of bioluminescent signal at
24 h after MCAO in nestin-luc-GFP mice. Using DLIT algorithms and structural images of the mouse, these data were transformed into 3D images. The
more intense signal is seen in the frontal part of the brain of the mouse and strong activation of signal on the site of ischemia
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involved in neurogenesis, including the SVZ and striatum
as well as the hippocampus. These findings were further
validated by immunohistochemistry analysis (Fig. 3a–j).
Importantly, recorded signal distribution was consistent
with our previous results obtained by in vivo imaging of
different reporter mice following transient MCAO [7, 10].
Previous evidence suggests that the nestin-positive
progenitors may also give rise and differentiate into
GFAP-positive astrocytes; we next investigated the cellu-
lar expression/induction patterns of nestin after stroke.
Based on the results obtained by in vivo imaging, i.e.,
peak signal induction of nestin (see Fig. 2g), the ischemic
brains were collected at 3–7 days after ischemia and
stained for nestin and GFP. Because previous evidence
suggests a marked up-regulation of nestin in reactive
astrocyte surrounding the lesion site, we first analyzed
the pattern of the nestin-driven GFP expression in the
peri-infarct/stroked zone. The specificity of transgene
expression was then assessed by analysis of GFP expres-
sion in the cell types known to be highly responsive to
brain damage. Immunofluorescence analysis of the peri-
infarct region showed co-localization of the nestin-
driven transgene GFP with endogenous protein or with
the known astrocyte marker GFAP (Fig. 3a–g). Next, the
cellular expression pattern of the GFP transgene was
also assessed in the hippocampus (Fig. 4h–j) and in the
SVZ (Fig. 3k–m), neuroanatomical regions known to be
involved in the adult brain neurogenesis. We observed a
marked up-regulation of nestin in the ipsilateral dentate
gyrus at 1-week post-injury (Fig. 3n). Namely, the quan-
titative analysis revealed a significant increase in the
numbers of the GFP and nestin-positive cells at 7 days
after initial stroke. The similar pattern of the GFP and
nestin immunoreactivities was observed at the SVZ re-
gion (Fig. 3o). Taken together, quantitative analysis of
the GFP, GFAP, and nestin-positive cells revealed a sig-
nificant increase in cell numbers starting at 3 days and
peaking 7 days after stroke (Fig. 3n–q). Importantly, and
as revealed by combined in vivo imaging and double-
immunofluorescence data, the early peak of the nestin
signal observed by in vivo imaging (biophotonic/bio-
luminescence imaging protocol) (24–72 h after stroke) is
caused, in part, by a marked increase in the nestin signal
arising from the activated astrocytes located at the peri-
infarct region.
Acute and chronic LPS treatments induce robust and
transient induction of the nestin signals
Contrary to brain response to injuries, including stroke,
previous evidence suggests that the acute and chronic
inflammation may have a negative impact on neurogen-
esis [22–27]. To assess the spatial and temporal dynamics
of the nestin signal in the context of neuroinflammatory
conditions, we used a well-established model of the LPS-
induced acute and chronic inflammation. We used two
different approaches. The nestin-luc/GFP transgenic mice
Fig. 3 Expression of nestin-positive cells in the SVZ, DG, and stroke area (SA) regions. Schematic presentation of the stroke area (a). Analysis of brain
sections by immunofluorescence revealed an increase in expression of nestin-positive cells of the SA (b–g), DG (h–j), and SVZ (k–m) 7 days after MCAO.
Statistical analysis showed a significant increase of nestin-positive cells after MCAO, particularly at 7 days of MCAO in the DG (n), SVZ (o), and SA (p–q)
(*p≤ 0.05, **p≤ 0.01, ***p≤ 0.001). The number of GFAP-positive cells was also increased in the stroke area region at 3 and 7 days. The white arrowheads show
the double positive cells. Statistical analysis was performed by one-way ANOVA followed by Tukey’s multiple test (n=3–5). Scale bar: 100 μm
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were injected by single dose of LPS or treated chronic-
ally over 14 days (see the “Methods” section) (Fig. 4a–
l). The in vivo analysis of bioluminescence revealed
that, when compared to baseline levels, a single LPS in-
jection induced a transient but robust increase of the
nestin signal peaking 24 h after initial stimuli (Fig. 4a–
d). Interestingly, after the single LPS injection, the sig-
nal tends to decline after 3 days reaching the baseline
levels at 5–7 days (Fig. 4m). In the chronic inflamma-
tory model, the nestin signal was up-regulated after
24 h of LPS and tends to increase after every 3 days
(periodical injection) (Fig. 4e–l). However, at the end of
the 14 days, the recorded signals were below the base-
line levels (Fig. 4m). The cellular expression patterns of
nestin were further confirmed by immunofluorescence
analysis. The quantitative analysis of the nestin and
GFAP expression reveals a marked increase in nestin
(Fig. 5a–c, g–i) and GFAP (Fig. 5d, f, j–l)
immunoreactivities in the dentate gyrus and in the SVZ
1 day after LPS injection. This increase in immunoreac-
tivities correlates with the increase in the numbers of
nestin and GFAP-positive cells in the two regions ana-
lyzed. The number of nestin and GFAP-positive cells is
significantly increased at day 1 and starts to decrease in
the DG and in the SVZ as early as 4 days after LPS in-
jection to reach lower than the basal level at 14 days
(Fig. 5m, n). In order to determine whether the ob-
served increase in the number of the GFAP-positive
cells is due to an augmentation in proliferation, we per-
formed double immunofluorescence for Ki67 (marker
of proliferation) and GFAP 1 day after LPS injection. In
fact, very few GFAP cells expressed the proliferation
marker Ki67 in the SVZ (Fig. 5o–q) or DG (Fig. 5r–t).
Thus, our results suggest that the observed increase in
the number of GFAP-positive cells after LPS, at the
tested time point, is not due to proliferation [28].
Fig. 4 In vivo imaging of the acute and chronic inflammatory immune response in the brain of nestin-luc-GFP mice. Single LPS injection showed robust
induction of the nestin signal after 24 h (a, b). The signal tends to decrease after 24 h (dotted blue line) (c, d). Repetitive injections of LPS (5 mg/kg) every
3 days produced a second small peak in the nestin signal intensity after 4 days (solid blue line) (e–l). m Quantitative analysis of the nestin signal by in vivo
imaging after LPS injection showed a significant increase in signal intensities 24 h after challenge in both experimental paradigm (acute and chronic LPS
administration protocols) (LPS vs baseline ***p≤ 0.0001, n= 8–10/group). The nestin signal gradually decreased to reach baseline level at day 3. Chronic
exposure of LPS resulted in fluctuation of the nestin signal expression 2 weeks after of LPS treatment (LPS vs baseline *p≤ 0.05, **p≤ 0.01, ***p≤ 0.001)
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Inflammation and brain ischemia increase microglial
expression of nestin
While nestin have been widely considered as a putative
neuronal stem cell marker, in neuroinflammatory and in
post-injury conditions, nestin could also be observed in
activated and GFAP-positive astrocytes (see Figs. 3 and 4)
[29, 30]. Importantly, the immunofluorescence analysis of
the brain sections after stroke revealed several GFP-
positive cells with glial morphology that were not positive
for the astrocyte marker GFAP. We next asked whether
resident glial cells including microglia may express and/or
up-regulate nestin in neuroinflammatory conditions. We
analyzed activated microglial cells for nestin expression at
different time points following LPS challenge and after
MCAO. Our areas of interest were the DG and SVZ re-
gions, and since MCAO injury affects the area close to the
SVZ, this region also included a peri-infarct zone/stroke
area. As expected, the LPS challenge and the inflamma-
tory response following MCAO were characterized by a
marked increase in Iba-1 staining (Fig. 6a–r). Interestingly,
a double-immunofluorescence analysis revealed that a sig-
nificant number of activated microglia/macrophages were
indeed positive for nestin. As shown in Fig. 6s–z, quantita-
tive analysis of the Iba-1 and the Iba-1/nestin-positive cells
revealed that following the LPS challenge, a number of
Iba-1/nestin-positive cells showed the highest increase
24 h after the LPS challenge, while following MCAO, the
number of nestin-positive microglia/macrophages peaked
Fig. 5 Increased number of GFAP- and nestin-positive cells after acute and chronic LPS administration. Immunofluorescence analysis of nestin
and GFAP expression 1 day after LPS showed an increased number of positive cells in the SVZ (a, b, d, e) and DG (g, h, j, k). 14 days of LPS ad-
ministration lead to a decrease in the number of NPGs in both neurogenic regions (c, f, i, l). All presented panels came from independent staining
experiments. Immunofluorescence analysis of GFAP and Ki67 reveals that a small number of Ki67+ cells are also GFAP positives in the SVZ (m–o)
and DG (p–r) 1 day after LPS. Statistical analysis of nestin- (s) and GFAP- (t) positive cells have been performed in both the SVZ and DG regions.
As by immunofluorescence experiment, a significant increase of nestin and GFAP expression was observed after 24 h after LPS. The white
arrowheads (o–t) show the double positive cells. Statistical analysis was performed by one-way ANOVA followed by Tukey’s multiple test
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 (n = 5). Scale bar: 100 μm
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7 days after stroke followed by decline at 14 days fol-
lowing initial ischemic injury (Fig. 6u, v, y, z). Note
that the SVZ region in the stroke-affected mice also
comprises an ischemic area affected by MCAO
(Fig. 6p–r). Here it is important to mention that, in
the brain, the systemic LPS-induced microglial activa-
tion does not lead to infiltration of the peripheral
cells; thus, Iba-1 and Iba-1/nestin-positive cells are indeed
resident microglia [31]. In the stroke model, however, we
cannot exclude that the subset of the nestin/Iba-1-positive
cells may be of peripheral origin, thus representing the
microglia/macrophage population.
One of the important features of microglial activation,
especially in the context of ischemic injury, is a robust
proliferative response [11, 32]. Thus, we next investi-
gated whether nestin/Iba-1+ cells are indeed dividing
microglia. We performed immunofluorescence analysis
for Ki67 (marker of proliferation), nestin, and Iba-1.
Given the temporal differences in the peak numbers of
the Iba-1-positive cells following LPS challenge and
MCAO (see Fig. 6), identification analysis of the Iba-1/
nestin/Ki67-positive cells was performed either 24 h
(LPS) or 72 h (MCAO) following initial brain challenge.
As revealed in Fig. 7, following stroke, only few Iba-1/
nestin/Ki67-positive cells were detected in the stroke
area (SA), DG, and SVZ 72 h after MCAO (Fig. 7a–p).
The similar findings were obtained following LPS chal-
lenge (Fig.7m–t). Namely, we identified only few Iba-1/
nestin/Ki67-positive cells in the DG and SVZ. To further
confirm that microglial cells up-regulate nestin in in-
flammatory conditions, we performed additional series
of in vitro experiments using primary glial cultures,
enriched in microglia. Indeed as revealed in Fig. 7u–bb,
the LPS treatment was associated with a robust induc-
tion of nestin in CD11b-positive cells. In addition, the
triple Iba-1/nestin/Ki67 staining revealed that some of the
nestin-positive microglial cells were dividing (Fig. 7bb).
Taken together, our results strongly suggest that
following injuries and in the context of acute innate
immune challenge, in addition to reactive astrocytes,
Fig. 6 LPS injection showed an increased expression of Iba-1+, nestin+, and Iba-1+/nestin+ cells in DG (a-f) and SVZ (j-o) when compare to base-
line level. Most of the nestin cells are co-localized with Iba-1 positive cells (white arrowhead). 3 days after MCAO, Iba-1+, nestin+ and Iba-1+/nestin
+ cells were observed in DG (g-i) and in SVZ (p-r)
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activated Iba-1 microglia/macrophages strongly up-
regulate nestin. This suggests that nestin may serve
as a context-dependent marker of activated micro-
glia/macrophages.
Discussion
Nestin, a class VI intermediate filament, is a well-
established putative neuronal stem cell marker. Here we
describe the nestin-luc/GFP reporter mouse model as a
novel transgenic tool for real-time analysis and/or
visualization of the nestin signals from the brains of liv-
ing animals. Using in vivo biophotonic/bioluminescence
imaging, we were able to visualize the baseline levels, as
well as the spatial and temporal dynamics of the nestin
biophotonic signal induction following ischemic injury
and in the experimental paradigms of the acute and
chronic neuroinflammation. Here it is important to men-
tion that in all experimental paradigms, analysis of the
fluorescence GFP transgene signal at the cellular level re-
vealed a co-expression between endogenous nestin and the
Fig. 7 Proliferative response of nestin+/Iba-1+ cells after inflammatory stimuli. a–l A strong proliferative response, seen by the immunoreactivity
for Ki67, is induced in the brain 72 h after MCAO in the SA (a–d), DG (e–h), and SVZ (i–l) regions. The vast majority of the proliferative cells are
CD11b+, and very few nestin+/CD11b+/Ki67+ can be found in the 3 regions studied (white arrowheads). 24 h after LPS injection, Ki67
immunoreactivity is found in the DG (m–p) and SVZ (q–t). The Ki67+ cells are either CD11b+ or nestin+, and very few cells in proliferation express
both markers (white arrowheads). Primary glial cell culture showed a strong induction of nestin immunoreactivity and proliferation after LPS
treatment in CD11b+ cells (white arrowheads) (u–bb). Scale bar: 50 and 100 μm
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nestin-driven GFP transgene. This suggests that nestin-luc/
GFP reporter mouse represents a valid model system for
real-time analysis of nestin induction and/or expression
patterns. By combining in vivo bioluminescence/biopho-
tonic imaging with double immunofluorescence, we report
here that in baseline, physiological conditions, in the adult
brain, nestin expression is indeed restricted to neuronal
progenitor cells. Thus, the obtained in vivo biophotonic
signal can be used to assess neurogenic activity from the
brains of adult mice. Importantly, ischemic brain injury as
well as controlled innate immune challenge induced sig-
nificant increase of the nestin signal in vivo. Contrary to
physiological conditions where the GFP signal co-localized
perfectly with nestin-positive progenitors, the double-
immunofluorescence analysis of the nestin-driven trans-
gene gfp revealed, however, that in neuroinflammatory
conditions, the cellular expression and/or induction of the
nestin biophotonic signal was not restricted to neuronal
progenitors. As expected, we observed a marked increase
in nestin expression/induction in the GFAP-positive react-
ive astrocytes. However, to our surprise, following LPS
challenge as well as after MCAO, we observed a significant
increase in the nestin expression in activated Iba-1 micro-
glia/macrophages (see Figs. 5 and 6).
Brain injuries and neurodegenerative disorders are asso-
ciated with acute and chronic brain inflammation. The re-
lationship between brain inflammation and the regulation
of neurogenesis has been well documented and remains
the subject of intense investigation. Notably, recent col-
lective evidence indicates that neurogenesis is affected
during brain injury and in distinct neuroinflammatory
conditions by the dysregulation of cytokines, chemokines,
neurotransmitters, and reactive oxygen species caused by
inflammation and mediated by activated macrophages,
microglia, and reactive astrocytes [33–42]. Multiple
models of ischemic-induced inflammation have demon-
strated an increase in neurogenesis [33–42]. On the other
hand and contrary to ischemic injury that has been associ-
ated with a strong induction of neurogenesis in the SVZ
and DG area, inflammation as well as irradiation have
been generally thought to disrupt progenitor cell prolifera-
tion and adult neurogenesis [43]. In our previous work,
we and others have shown that doublecortin-positive cells
in baseline conditions as well as after ischemic injury
express innate immune receptors suggesting an intense di-
alog between the immune system and NPGs [6, 7]. Nestin
is a putative marker of NPGs; importantly, however, nestin
expressing NPGs in addition to new neurons may give a
rise to a wide variety of cells including astroglia and oligo-
dendrocytes [2, 3, 44]. Thus, we hypothesize here that
neuroinflammatory conditions and injuries may sig-
nificantly affect and/or contribute to a differentiation
of the nestin-positive cells and thus induce the shift
towards gliosis.
A novel transgenic tool that we generated in our la-
boratory allowed us to investigate the role and/or spatial
and temporal dynamics of the nestin expressing cells in
brain response to injury and in neuroinflammatory con-
ditions. For example, a great advantage of our in vivo
model system is that it allowed us to track how nestin
expressing cells are responding to different types of neu-
roinflammatory conditions directly from the brains of
intact animals (see Figs. 3, 4, and 5). On the other hand,
a co-expression of the fluorescence reporter GFP per-
mitted identification of the cells expressing nestin fol-
lowing different stimuli. As expected, and in accordance
with the previous work [45], MCAO was associated with
a marked increase in nestin expressing reactive astro-
cyte. The similar induction pattern was observed follow-
ing LPS stimuli however with slightly different temporal
dynamics (see Figs. 4 and 5). Importantly, a chronic ex-
posure to LPS resulted in marked decrease in the nestin
biophotonic/bioluminescence signal as well loss of im-
munostaining. Interestingly, during our analysis, we ob-
served a number of cells having glial morphology
expressing nestin-driven transgene GFP but were not
GFAP positive. In keeping with recent and rather intri-
guing findings by Elmore and colleagues [4] describing
that in microglia-depleted brain, repopulation of micro-
glia occurs through proliferation of nestin-positive cells,
we next asked whether the unidentified nestin express-
ing cells are indeed activated microglia/macrophages. To
our surprise, the analysis of immunostaining, in both
neuroinflammatory conditions, revealed a subpopulation
of the Iba-1/nestin-positive cells. Although the origin of
the nestin expressing microglia remains unclear [46], the
increase in Iba-1/nestin-positive cells was more pro-
nounced after stroke, where 7 days after injury, approx.
40% of activated microglial cells were nestin positive
(Fig. 6). Hence, our data suggest that in addition to re-
active astrocytes in response to injury and neuroinflam-
mation, activated microglial cells may express stem cell
markers like nestin.
Conclusions
In summary, our results suggest that neuroinflammatory
conditions such as brain ischemia and innate immune
challenge strongly up-regulate nestin signals in the brain
of living animals. Interestingly, while in physiological
conditions, and in the adult brain, nestin expression is
restricted to NPGs in their respective niches and the
neuroinflammatory conditions are associated with
marked induction of nestin in astrocytes as well as in ac-
tivated microglia/macrophages. Based on our results, we
propose that nestin may serve as a context-dependent
biomarker of inflammatory response in glial cells includ-
ing activated brain microglia/macrophages.
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Additional file
Additional file 1: Figure S1. Negative controls. Representative
photomicrographs of imaging of WT mice in baseline (A), 24 h after
MCAO (B), and 24 h after LPS (C). No bioluminescence signal can be
observed in the three groups of experimental animals confirming the
specificity of the signal emission in the nestin-luc-GFP mice. No GFP im-
munoreactivity can be observed in the brain sections of WT mice and
24 h after stroke and LPS (D–I), and no unspecific staining can be ob-
served with the secondary antibody, Alexa 594 anti-mouse, used in this
study (J, K). Note that DAPI staining is added to visualize neuroanatomical
region (DG) of the negative controls. Scale bar: 100 μm. (TIF 2419 kb)
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